Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.760
-0.030 (-1.08%)
Dec 30, 2025, 11:32 AM EST - Market open
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.1 billion as of December 30, 2025. Its market cap has decreased by -58.10% in one year.
Market Cap
1.10B
Enterprise Value
845.34M
1-Year Change
-58.10%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.10B, an increase of 347.93%. That is a compound annual growth rate of 14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 1.11B | -50.90% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 232.28B |